Pharmacokinetic data on estradiol in light of the estring® concept. Estradiol and estring pharmacokinetics

Acta Obstetricia et Gynecologica Scandinavica, Supplement

Volumn 75, Issue 163, 1996, Pages 26-31

  Gabrielsson, Johan ^a  

^a PFIZER INC   (United States)

Author keywords

Estradiol; Estradiol vaginal ring; Pharmacodynamics; Pharmacokinetics

Indexed keywords

ESTRADIOL;

DRUG SAFETY; FEMALE; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; PHARMACODYNAMICS; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; VAGINA RING; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ESTROGEN THERAPY; METABOLISM; MIDDLE AGED; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION; VAGINA;

ADMINISTRATION, TOPICAL; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; VAGINA;

EID: 0029910229     PISSN: 03008835     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (3)

1. Dollery C, Therapeutic Drugs, Churchill & Livingstone 1991.
2. Frumar AM, Meldrum DR, Geola F, Shamonki IM, Tataryn IV, Deftos LJ et al. Relationship of fasting urinary calcium to circulating estrogen and body weight in postmenopausal women. J Clin Endocrinol Metab 1980; 50: 70-5.
3. Holmgren PÅ, Lindskog M, von Schuulz B. Vaginal rings for continuous low-dose release of oestradiol in the treatment of urogenital atrophy. Maturitas 1989; 11: 55-63.